These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34563875)

  • 41. Central nervous system complications and management in sickle cell disease.
    DeBaun MR; Kirkham FJ
    Blood; 2016 Feb; 127(7):829-38. PubMed ID: 26758917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Burden of neurological and neurocognitive impairment in pediatric sickle cell anemia in Uganda (BRAIN SAFE): a cross-sectional study.
    Green NS; Munube D; Bangirana P; Buluma LR; Kebirungi B; Opoka R; Mupere E; Kasirye P; Kiguli S; Birabwa A; Kawooya MS; Lubowa SK; Sekibira R; Kayongo E; Hume H; Elkind M; Peng W; Li G; Rosano C; LaRussa P; Minja FJ; Boehme A; Idro R
    BMC Pediatr; 2019 Oct; 19(1):381. PubMed ID: 31651270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stroke Recurrence in Nigerian Children With Sickle Cell Disease: Evidence for a Secondary Stroke Prevention Trial.
    Abdullahi SU; DeBaun MR; Jordan LC; Rodeghier M; Galadanci NA
    Pediatr Neurol; 2019 Jun; 95():73-78. PubMed ID: 30952488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Realizing effectiveness across continents with hydroxyurea: Enrollment and baseline characteristics of the multicenter REACH study in Sub-Saharan Africa.
    McGann PT; Williams TN; Olupot-Olupot P; Tomlinson GA; Lane A; Luís Reis da Fonseca J; Kitenge R; Mochamah G; Wabwire H; Stuber S; Howard TA; McElhinney K; Aygun B; Latham T; Santos B; Tshilolo L; Ware RE;
    Am J Hematol; 2018 Aug; 93(4):537-545. PubMed ID: 29318647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of alpha-thalassemia and Glucose-6-Phosphate Dehydrogenase deficiency with transcranial Doppler ultrasonography in Nigerian children with sickle cell anemia.
    Ojewunmi OO; Adeyemo TA; Oyetunji AI; Benn Y; Ekpo MG; Iwalokun BA
    J Clin Lab Anal; 2021 Jun; 35(6):e23802. PubMed ID: 33938598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Personalized Reminders Increase Screening for Stroke Risk in Children with Sickle Cell Anemia.
    Muntz DS; Bundy DG; Strouse JJ
    South Med J; 2016 Sep; 109(9):506-10. PubMed ID: 27598350
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Haemoglobin oxygen saturation, leucocyte count and lactate dehydrogenase are predictors of elevated cerebral blood flow velocity in Nigerian children with sickle cell anaemia.
    Ojewunmi OO; Adeyemo TA; Osuntoki AA; Imaga NA; Oyetunji AI
    Paediatr Int Child Health; 2018 Feb; 38(1):34-39. PubMed ID: 28388354
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial.
    Alvarez O; Yovetich NA; Scott JP; Owen W; Miller ST; Schultz W; Lockhart A; Aygun B; Flanagan J; Bonner M; Mueller BU; Ware RE;
    Am J Hematol; 2013 Nov; 88(11):932-8. PubMed ID: 23861242
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Approximately 40 000 children with sickle cell anemia require screening with TCD and treating with hydroxyurea for stroke prevention in three states in northern Nigeria.
    Galadanci AA; Galadanci NA; Jibir BW; Abdullahi SU; Idris N; Gambo S; Ali Abubakar SA; Kabo NA; Bello-Manga H; Haliru L; Bashir I; Aliyu MH; Galadanci JA; DeBaun MR
    Am J Hematol; 2019 Nov; 94(11):E305-E307. PubMed ID: 31423630
    [No Abstract]   [Full Text] [Related]  

  • 50. Stroke prevention in the young child with sickle cell anaemia.
    Roberts L; O'Driscoll S; Dick MC; Height SE; Deane C; Goss DE; Pohl K; Rees DC
    Ann Hematol; 2009 Oct; 88(10):943-6. PubMed ID: 19455330
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospects for primary stroke prevention in children with sickle cell anaemia.
    Jordan LC; Casella JF; DeBaun MR
    Br J Haematol; 2012 Apr; 157(1):14-25. PubMed ID: 22224940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design of the DREPAGREFFE trial: A prospective controlled multicenter study evaluating the benefit of genoidentical hematopoietic stem cell transplantation over chronic transfusion in sickle cell anemia children detected to be at risk of stroke by transcranial Doppler (NCT 01340404).
    Chevret S; Verlhac S; Ducros-Miralles E; Dalle JH; de Latour RP; de Montalembert M; Benkerrou M; Pondarré C; Thuret I; Guitton C; Lesprit E; Etienne-Julan M; Elana G; Vannier JP; Lutz P; Neven B; Galambrun C; Paillard C; Runel C; Jubert C; Arnaud C; Kamdem A; Brousse V; Missud F; Petras M; Doumdo-Divialle L; Berger C; Fréard F; Taieb O; Drain E; Elmaleh M; Vasile M; Khelif Y; Bernaudin M; Chadebech P; Pirenne F; Socié G; Bernaudin F
    Contemp Clin Trials; 2017 Nov; 62():91-104. PubMed ID: 28821470
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Barriers and facilitators to a task-shifted stroke prevention program for children with sickle cell anemia in a community hospital: a qualitative study.
    Bello-Manga H; Haliru L; Ahmed K; Ige S; Musa H; Muhammad-Idris ZK; Monday B; Sani AM; Bonnet K; Schlundt DG; Varughese T; Tabari AM; DeBaun MR; Baumann AA; King AA
    Implement Sci Commun; 2024 Jan; 5(1):10. PubMed ID: 38225633
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Underweight children older than 5 years with sickle cell anemia are at risk for early mortality in a low-resource setting.
    Klein LJ; Abdullahi SU; Gambo S; Stallings VA; Acra S; Rodeghier M; DeBaun MR
    Blood Adv; 2023 Jun; 7(11):2339-2346. PubMed ID: 36383708
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic blood transfusion for primary and secondary stroke prevention in Nigerian children with sickle cell disease: a 5-year appraisal.
    Lagunju IA; Brown BJ; Sodeinde OO
    Pediatr Blood Cancer; 2013 Dec; 60(12):1940-5. PubMed ID: 23956197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening children for sickle cell vasculopathy: guidelines for transcranial Doppler evaluation.
    Bulas D
    Pediatr Radiol; 2005 Mar; 35(3):235-41. PubMed ID: 15703903
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Implementation of a Process for Initial Transcranial Doppler Ultrasonography in Children With Sickle Cell Anemia.
    Crosby LE; Joffe NE; Davis B; Quinn CT; Shook L; Morgan D; Simmons K; Kalinyak KA
    Am J Prev Med; 2016 Jul; 51(1 Suppl 1):S10-6. PubMed ID: 27320459
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload.
    Ware RE; Schultz WH; Yovetich N; Mortier NA; Alvarez O; Hilliard L; Iyer RV; Miller ST; Rogers ZR; Scott JP; Waclawiw M; Helms RW
    Pediatr Blood Cancer; 2011 Dec; 57(6):1011-7. PubMed ID: 21826782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Building capacity to reduce stroke in children with sickle cell anemia in the Dominican Republic: the SACRED trial.
    Sánchez LM; Nieves RM; Latham T; Stuber S; Luden JR; Urcuyo GS; Berges ME; Florencio C; Gonzalez C; Del Villar P; Lane A; Schultz W; Jeste N; Mena R; Ware RE
    Blood Adv; 2018 Nov; 2(Suppl 1):50-53. PubMed ID: 30504201
    [No Abstract]   [Full Text] [Related]  

  • 60. Implementation of transcranial Doppler ultrasonography screening and primary stroke prevention in urban and rural sickle cell disease populations.
    Hussain S; Nichols F; Bowman L; Xu H; Neunert C
    Pediatr Blood Cancer; 2015 Feb; 62(2):219-223. PubMed ID: 25381872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.